Victoria D. Harker
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Xylem sees broad analyst price target cuts. Several major banks, including Mizuho, Oppenheimer, and Citigroup, recently lowered their price targets for Xylem. While most firms maintained positive ratings, the reduction in targets reflects a more conservative outlook on the stock's near-term value. The company also announced it will participate in upcoming investor conferences to discuss its strategy.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Philip Morris Raises Dividend 8.8% Ahead of Q3 Earnings. Philip Morris International increased its dividend by 8.8%, a move that highlights the company's focus on shareholder returns. This update comes just before the Q3 earnings report, where investors are watching for signs of competitive pressure in the market. The company also released a study detailing its economic footprint in Europe over the last five years.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Stride Adds Board Members, Forms Capital Committee, Acquires Clio. Stride is expanding its corporate governance by appointing Steven Guttentag and Dylan Haggart to the board and creating a new capital allocation committee. The company also announced a majority investment in Clio, a Greek yogurt bar brand, marking a step into consumer products. Meanwhile, BMO Capital lowered its price target to $90 while maintaining a Market Perform rating.
Transaction History
| HII | ▲ Buy | Grant | 177 | $49K | 10/1/2026 | View on chart |
| HII | ▲ Buy | Grant | 39 | $0 | 9/11/2026 | View on chart |
| HII | ▼ Sell | Open Market | 723 | $241K | 8/7/2026 | View on chart |
| HII | ▲ Buy | Grant | 174 | $49K | 7/1/2026 | View on chart |
| HII | ▲ Buy | Grant | 36 | $0 | 6/12/2026 | View on chart |
| XYL | ▲ Buy | Grant | 1,711 | $200K | 5/14/2026 | View on chart |
| PM | ▲ Buy | Grant | 1,119 | $190K | 5/6/2026 | View on chart |
| HII | ▲ Buy | Grant | 123 | $48K | 4/1/2026 | View on chart |
| HII | ▲ Buy | Grant | 26 | $0 | 3/13/2026 | View on chart |
| HII | ▲ Buy | Grant | 139 | $49K | 1/2/2026 | View on chart |
| HII | ▲ Buy | Grant | 33 | $0 | 12/12/2025 | View on chart |
| XYL | ▼ Sell | Open Market | 1,700 | $252K | 11/4/2025 | View on chart |
| HII | ▼ Sell | Open Market | 1,000 | $317K | 11/4/2025 | View on chart |
| HII | ▲ Buy | Grant | 144 | $41K | 10/1/2025 | View on chart |
| HII | ▲ Buy | Grant | 38 | $0 | 9/12/2025 | View on chart |
| HII | ▼ Sell | Open Market | 1,000 | $269K | 8/5/2025 | View on chart |
| XYL | ▼ Sell | Open Market | 1,800 | $259K | 8/4/2025 | View on chart |
| HII | ▲ Buy | Grant | 167 | $41K | 7/1/2025 | View on chart |
| HII | ▲ Buy | Grant | 44 | $0 | 6/13/2025 | View on chart |
| XYL | ▲ Buy | Grant | 1,300 | $165K | 5/13/2025 | View on chart |
| PM | ▲ Buy | Grant | 1,002 | $175K | 5/7/2025 | View on chart |
| HII | ▲ Buy | Grant | 204 | $41K | 4/1/2025 | View on chart |
| HII | ▲ Buy | Grant | 52 | $0 | 3/14/2025 | View on chart |
| HII | ▲ Buy | Grant | 219 | $41K | 1/2/2025 | View on chart |
| HII | ▲ Buy | Grant | 53 | $0 | 12/13/2024 | View on chart |
| HII | ▲ Buy | Grant | 155 | $41K | 10/1/2024 | View on chart |
| HII | ▲ Buy | Grant | 37 | $0 | 9/13/2024 | View on chart |
| XYL | ▼ Sell | Open Market | 2,760 | $352K | 9/9/2024 | View on chart |
| HII | ▲ Buy | Grant | 167 | $41K | 7/1/2024 | View on chart |
| HII | ▲ Buy | Grant | 41 | $10K | 6/14/2024 | View on chart |
| XYL | ▲ Buy | Grant | 1,156 | $0 | 5/16/2024 | View on chart |
| PM | ▲ Buy | Grant | 2,416 | $236K | 5/8/2024 | View on chart |
| HII | ▲ Buy | Grant | 143 | $41K | 4/1/2024 | View on chart |
| HII | ▲ Buy | Grant | 33 | $10K | 3/8/2024 | View on chart |
| HII | ▲ Buy | Grant | 158 | $41K | 1/2/2024 | View on chart |
| HII | ▲ Buy | Grant | 39 | $10K | 12/8/2023 | View on chart |
| XYL | ▼ Sell | Open Market | 2,000 | $213K | 12/8/2023 | View on chart |
| HII | ▲ Buy | Grant | 198 | $40K | 10/2/2023 | View on chart |
| HII | ▲ Buy | Grant | 43 | $9K | 9/8/2023 | View on chart |
| HII | ▲ Buy | Grant | 174 | $40K | 7/3/2023 | View on chart |
| HII | ▲ Buy | Grant | 42 | $9K | 6/9/2023 | View on chart |
| XYL | ▲ Buy | Grant | 1,580 | $0 | 5/18/2023 | View on chart |
| HII | ▲ Buy | Grant | 191 | $40K | 4/3/2023 | View on chart |
| HII | ▲ Buy | Grant | 44 | $9K | 3/10/2023 | View on chart |
| HII | ▲ Buy | Grant | 175 | $40K | 1/3/2023 | View on chart |
| HII | ▲ Buy | Grant | 38 | $9K | 12/9/2022 | View on chart |
| HII | ▲ Buy | Grant | 176 | $40K | 10/3/2022 | View on chart |
| HII | ▲ Buy | Grant | 36 | $8K | 9/9/2022 | View on chart |
| XYL | ▼ Sell | Open Market | 5,000 | $501K | 8/10/2022 | View on chart |
| HII | ▲ Buy | Grant | 181 | $40K | 7/1/2022 | View on chart |
| HII | ▲ Buy | Grant | 40 | $0 | 6/10/2022 | View on chart |
| XYL | ▲ Buy | Grant | 1,812 | $0 | 5/12/2022 | View on chart |
| HII | ▲ Buy | Grant | 197 | $40K | 4/1/2022 | View on chart |
| HII | ▲ Buy | Grant | 41 | $8K | 3/11/2022 | View on chart |
| HII | ▲ Buy | Grant | 215 | $40K | 1/3/2022 | View on chart |
| LRN | ▲ Buy | Grant | 4,362 | $0 | 1/3/2022 | View on chart |
| HII | ▲ Buy | Grant | 45 | $8K | 12/10/2021 | View on chart |
| HII | ▲ Buy | Grant | 167 | $32K | 10/1/2021 | View on chart |
| HII | ▲ Buy | Grant | 39 | $8K | 9/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
HII names Greg Ennis CFO of Mission Technologies, secures $5.1B contract
Huntington Ingalls Industries announced that Greg Ennis has been promoted to chief financial officer of its Mission Technologies division. The company also secured a $5.1 billion contract to overhaul the USS Truman, adding to its defense backlog. Analysts at Goldman Sachs have added HII to their conviction list, highlighting the firm among top warship builders. The news comes as the stock trades near the middle of its 52‑week range.
HII names Greg Ennis CFO of Mission Technologies, secures $5.1B contract. Huntington Ingalls Industries announced that Greg Ennis has been promoted to chief financial officer of its Mission Technologies division. The company also secured a $5.1 billion contract to overhaul the USS Truman, adding to its defense backlog. Analysts at Goldman Sachs have added HII to their conviction list, highlighting the firm among top warship builders. The news comes as the stock trades near the middle of its 52‑week range.